Palico, the private equity fund marketplace

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

About OrbiMed Asia

OrbiMed Asia is a private equity general partner firm headquartered in Shanghai, China and has other offices in India.

Invest in OrbiMed Asia funds

Hundreds of fund managers are currently fundraising on Palico.

Already a member? Log in.

Funds managed by OrbiMed Asia

Closed and liquidated funds managed by OrbiMed Asia:
Fund name Size Vintage Status
OrbiMed Asia Partners III USD 551m 2017 Closed
OrbiMed Asia Partners II USD 325m 2014 Closed
Caduceus Asia Partners USD 175m 2008 Closed

News about OrbiMed Asia

Sep 27, 2017

OrbiMed invested $42.5m in Uquifa, the active pharmaceutical ingredient unit of India-listed pharmaceuticals business firm Vivimed Labs.

Sep 13, 2017

The Asian Development Bank has invested $60m in OrbiMed Asia Partners III, the third Asian PE fund of healthcare-focused GP OrbiMed.

Jun 30, 2017

Zai Lab, a pharmaceutical company, raised $30m in Series C from existing investor OrbiMed.

Read more news about OrbiMed Asia

Other investment strategies pursued by the same firm

This firm also pursues other investment strategies:

Invest in Private Equity

Find and invest in PE funds, secondaries and co-investments that match your investment strategy.

Already a member? Log in.